Cell death and the mitochondria: therapeutic targeting of the BCL‐2 family‐driven pathway

Explore this paper's citation graph

Summary

Modulating the activity of the BCL‐2 family of proteins with small molecules or peptides is an attractive but challenging therapeutic goal and evidence that this strategy is likely to have a positive effect on the treatment of still poorly addressed medical conditions is provided.

Type
article
Published
2014-04-01
Cited by
118
References
145
Access
Open access

Keywords

Mitochondrion, Cell biology, Programmed cell death, Biology, Bcl-2 family

References

Cited by

Related papers